FNCHQ Finch Therapeutics Group, Inc.

Fundamentals / CIK 0001733257 / USD

Finch Therapeutics Group, Inc. reported $0 in revenue and a net loss of $14.17M for the trailing twelve months ended June 30, 2024 (down 87.6% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FNCHQ in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2020 to 2023), reported in USD.

$30.37M$15.19M$0-$108.8MFY 2020 Revenue: $7.72MFY 2020 Net Income: -$39.34M2020FY 2021 Revenue: $18.53MFY 2021 Net Income: -$58.16M2021FY 2022 Revenue: $861KFY 2022 Net Income: -$114.6M2022FY 2023 Revenue: $107KFY 2023 Net Income: -$74.75M2023

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue $107K $861K $18.53M $7.72M
Research & Development $7.20M $52.86M $57.28M $33.14M
Total Operating Expenses $83.97M $116.5M $78.52M $47.16M
Operating Income -$83.86M -$115.6M -$59.98M -$39.44M
EBITDA -$82.34M -$110.1M -$57.68M -$38.65M
Income Before Tax -$78.22M -$114.6M -$58.16M -$39.34M
Income Tax Expense -$3.46M $0 $0 $0
Net Income -$74.75M -$114.6M -$58.16M -$39.34M
Basic EPS -$46.59 -$72.12 -$44.44 -$145.04
Diluted EPS -$46.59 -$72.12 -$44.44 -$145.04
Basic Shares Outstanding 1.6M 1.6M 1.3M 271.2K
Diluted Shares Outstanding 1.6M 1.6M 1.3M 271.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
Revenue $0 $0 $0 $0 $0 $107K $8.0K $138K
Research & Development $0 $0 $0 $0 $203K $7.00M $11.55M $11.86M
Total Operating Expenses $6.11M $5.20M $4.42M $3.78M $9.88M $65.89M $27.76M $40.77M
Operating Income -$6.11M -$5.20M -$4.42M -$3.78M -$9.88M -$65.78M -$27.75M -$40.63M
EBITDA -$6.07M -$5.16M -$4.37M -$3.73M -$9.82M -$64.42M -$26.34M -$39.23M
Income Before Tax -$4.83M -$3.88M -$3.04M -$2.42M -$6.95M -$65.81M -$27.01M -$40.37M
Income Tax Expense $0 $0 $0 $0 $0 -$3.46M $0 $0
Net Income -$4.83M -$3.88M -$3.04M -$2.42M -$6.95M -$62.35M -$27.01M -$40.37M
Basic EPS -$3.01 -$2.41 -- -$1.51 -$4.33 -$39.19 -- -$25.38
Diluted EPS -$3.01 -$2.41 -- -$1.51 -$4.33 -$39.19 -- -$25.38
Basic Shares Outstanding 1.6M 1.6M -- 1.6M 1.6M 1.6M -- 1.6M
Diluted Shares Outstanding 1.6M 1.6M -- 1.6M 1.6M 1.6M -- 1.6M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $25.12M $71.04M $133.5M $99.71M
Cash & Short-Term Investments $25.12M $71.04M $133.5M $99.71M
Accounts Receivable, Net $0 $144K $494K $1.03M
Total Current Assets $25.85M $74.55M $142.6M $106.2M
Property, Plant & Equipment, Net $594K $15.94M $19.64M $7.00M
Goodwill -- $0 $18.06M $18.06M
Other Non-Current Assets $0 $4.03M $4.91M $200K
Total Non-Current Assets $29.53M $88.39M $82.82M $59.17M
Total Assets $55.37M $162.9M $225.4M $165.3M
Accounts Payable $141K $1.10M $3.74M $2.62M
Deferred Revenue (Current) -- -- $0 $3.37M
Total Current Liabilities $4.08M $14.69M $14.79M $11.49M
Long-Term Debt $0 $14.65M $0 $1.81M
Deferred Revenue (Non-Current) -- -- $0 $10.26M
Other Non-Current Liabilities $0 $170K $7.0K $221K
Total Non-Current Liabilities $28.40M $52.54M $8.36M $16.52M
Total Liabilities $32.49M $67.23M $23.14M $28.00M
Total Debt (incl. Leases) $30.13M $52.34M $6.04M $1.81M
Common Stock $2.0K $2.0K $47K $8.0K
Retained Earnings -$350.4M -$275.6M -$161.0M -$102.8M
Total Stockholders' Equity $22.89M $95.71M $202.2M -$95.72M
Total Equity $22.89M $95.71M $202.2M -$95.72M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
Cash & Cash Equivalents $16.04M $20.76M $25.12M $28.78M $34.05M $41.68M $71.04M $85.29M
Cash & Short-Term Investments $16.04M $20.76M $25.12M $28.78M $34.05M $41.68M $71.04M $85.29M
Accounts Receivable, Net -- -- $0 $0 $0 $107K $144K $0
Total Current Assets $17.28M $21.18M $25.85M $29.92M $36.50M $43.40M $74.55M $90.62M
Property, Plant & Equipment, Net $507K $551K $594K $637K $732K $1.25M $15.94M $17.28M
Goodwill -- -- -- -- -- -- $0 $0
Other Non-Current Assets -- -- $0 $0 $0 $200K $4.03M $4.25M
Total Non-Current Assets $28.30M $28.92M $29.53M $29.57M $30.36M $35.64M $88.39M $97.35M
Total Assets $45.58M $50.09M $55.37M $59.49M $66.86M $79.04M $162.9M $188.0M
Accounts Payable $29K $47K $141K $357K $432K $2.55M $1.10M $1.06M
Total Current Liabilities $4.46M $3.50M $4.08M $4.88M $9.57M $13.21M $14.69M $13.81M
Long-Term Debt -- -- $0 $0 $0 $0 $14.65M $14.64M
Other Non-Current Liabilities -- -- $0 $0 $0 $0 $170K $125K
Total Non-Current Liabilities $26.89M $27.55M $28.40M $28.80M $29.39M $32.88M $52.54M $53.29M
Total Liabilities $31.36M $31.05M $32.49M $33.68M $38.96M $46.09M $67.23M $67.10M
Total Debt (incl. Leases) $28.99M $29.56M $30.13M $30.77M $31.04M $36.13M $52.34M $52.36M
Common Stock $2.0K $2.0K $2.0K $2.0K $2.0K $48K $2.0K $48K
Retained Earnings -$359.1M -$354.3M -$350.4M -$347.4M -$344.9M -$339.6M -$275.6M -$248.6M
Total Stockholders' Equity $14.22M $19.04M $22.89M $25.81M $27.89M $34.54M $95.71M $120.9M
Total Equity $14.22M $19.04M $22.89M $25.81M $27.89M $34.54M $95.71M $120.9M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$74.75M -$114.6M -$58.16M -$39.34M
Depreciation & Amortization $1.52M $5.51M $2.30M $790K
Stock-Based Compensation $1.93M $7.84M $4.16M $3.10M
Change in Receivables $143K $350K $540K $143K
Change in Payables -$956K -$2.26M $2.26M $440K
Operating Cash Flow -$31.50M -$74.85M -$67.13M -$31.33M
Capital Expenditure $0 -$2.18M -$15.98M --
Free Cash Flow -$31.50M -$77.03M -$83.12M --
Investing Cash Flow $1.33M -$2.18M -$15.92M -$2.63M
Financing Cash Flow -$16.16M $14.87M $119.1M $91.47M
Net Change in Cash -$46.33M -$62.16M $36.06M $57.51M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
Net Income -$4.83M -$3.88M -$3.04M -$2.42M -$6.95M -$62.35M -$27.01M -$40.37M
Depreciation & Amortization $44K $43K $44K $52K $57K $1.37M $1.41M $1.41M
Stock-Based Compensation $15K $28K $114K $335K $300K $1.18M $1.79M $2.10M
Change in Receivables $0 $0 -$1.0K $0 $107K $37K -$144K $174K
Change in Payables -$18K -$94K -$216K -$76K -$528K -$136K $37K $135K
Operating Cash Flow -$4.73M -$4.36M -$3.71M -$5.26M -$9.16M -$13.38M -$14.27M -$19.09M
Capital Expenditure $0 $0 $14K $0 $0 -$14K -$51K -$328K
Free Cash Flow -$4.73M -$4.36M -$3.69M -$5.26M -$9.16M -$13.39M -$14.32M -$19.42M
Investing Cash Flow $0 $0 $51K $20K $1.27M -$14K -$51K -$328K
Financing Cash Flow $0 $0 $0 $0 $4.0K -$16.16M $52K $41K
Net Change in Cash -$4.73M -$4.36M -$3.65M -$5.24M -$7.88M -$29.55M -$14.27M -$19.38M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -78374.8% -13425.4% -323.7% -510.9%
Net Profit Margin -69863.6% -13315.4% -313.8% -509.7%
Return on Equity (ROE) -326.6% -119.8% -28.8% --
Return on Assets (ROA) -135.0% -70.4% -25.8% -23.8%
Current Ratio 6.33x 5.08x 9.64x 9.24x
Quick Ratio 6.15x 4.85x 9.06x 8.77x
Debt to Equity 1.32x 0.55x 0.03x --
Revenue Growth (YoY) -87.6% -95.4% +140.1% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
Operating Margin -- -- -78374.8% -93214.8% -56936.0% -25536.8% -13425.4% -6443.8%
Net Profit Margin -- -- -69863.6% -85844.3% -54022.1% -24825.1% -13315.4% -6431.2%
Return on Equity (ROE) -99.6% -85.5% -326.6% -382.4% -490.0% -441.3% -119.8% -88.3%
Return on Assets (ROA) -31.1% -32.5% -135.0% -165.9% -204.4% -192.8% -70.4% -56.8%
Current Ratio 3.87x 6.05x 6.33x 6.13x 3.81x 3.29x 5.08x 6.56x
Quick Ratio 3.59x 5.93x 6.15x 5.90x 3.56x 3.16x 4.85x 6.18x
Debt to Equity 2.04x 1.55x 1.32x 1.19x 1.11x 1.05x 0.55x 0.43x
Revenue Growth (YoY) -- -100.0% -100.0% -100.0% -100.0% -69.8% -99.0% -98.8%
Source: SEC EDGAR CompanyFacts (CIK 0001733257) · from March 31, 2020 Data through June 30, 2024 · synced Nov 21, 2026, 05:04 UTC · Open in terminal